A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
Article in Infectious Diseases and Therapy (January 2024)
The most recent citing publications are shown below. View all 57 publications that cite this research output on Dimensions.
Article in Infectious Diseases and Therapy (January 2024)
Article in Journal of Controlled Release (September 2023)
Article in Cell Reports Medicine (May 2023)